81316642-Skills development for the Ghanaian pharmaceutical sector
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH · Eschborn, Hessen
Aktenzeichen 81316642veröffentlicht 06.09.2025DienstleistungenOffenes Verfahren
- Laufzeit
- 24 Monate
- bis zu 2 Verlängerungen
- Verfahren
- Offenes Verfahren
Dieses Verfahren ist abgeschlossen oder älter. Die Seite bleibt zur Information erreichbar.
Diese Frist ist vorbei. Das läuft gerade
Offene Ausschreibungen derselben Leistung im Gebiet Main-Taunus-Kreis.
- 10032182-Building the capacities of smallholder farmers on agriculture best practices, and climate smart agriculture in Upper EgyptDeutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH · EschbornFrist 10.12.2026
- Kommunale Gebäude- und InventarversicherungMain-Taunus-Kreis - Der Kreisausschuss · Hofheim am TaunusFrist 11.11.2026
- 10041825 - Supporting GIZ in the development of Green Climate Fund Concept Notes and Funding Proposals for up to three projectsDeutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH · EschbornFrist 01.12.2026
- 10032371 - Strengthening reproductive health and empowerment of young womenDeutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH · EschbornFrist 23.11.2026
Alle Ausschreibungen: Dienstleistungen in Hessen (154 offen)
Geplant · Neuausschreibung möglich
Vertrag endet voraussichtlich am – Neuausschreibung möglich
in 10 Monaten · aus Vertragsdatum und Laufzeit errechnet · Verlängerung möglich (bis zu 2-mal)
Endet ein Vertrag, schreibt die Vergabestelle die Leistung oft neu aus. Merken Sie den Vertrag vor: Wir erinnern Sie per E-Mail vor dem Vertragsende und melden, wenn dieselbe Vergabestelle eine ähnliche Leistung ausschreibt.
Verlängerungen sind nicht eingerechnet. Ob und wann neu ausgeschrieben wird, entscheidet die Vergabestelle. Die Erkennung einer Neuausschreibung ist eine Schätzung. Weitere auslaufende Verträge
Auf einen Blick
- Art des Auftrags
- Dienstleistungen
- Geschätzter Wert
- ?keine Angabe
- Laufzeit
- 24 Monatebis zu 2 Verlängerungen
- Lose
- 1
- Verfahren
- Offenes VerfahrenVgV, EU-weit
- Rahmenvereinbarung
- nein
- Ort der Leistung
- Eschborn65760, Main-Taunus-Kreis, Hessen
- Einreichung
- ?keine Angabe
Schnellprüfung für Bieter
- ?Unterlagen frei zugänglichkeine Angabe
- ?Elektronische Einreichung verpflichtendkeine Angabe
- ?Nebenangebote zugelassenkeine Angabe
- ?Mehrere Hauptangebote zugelassenkeine Angabe
- ?Laut Auftraggeber für KMU geeignetkeine Angabe
- ?Sicherheiten verlangtkeine Angabe
- ?Teilnahme vorbehalten (z. B. Werkstätten)keine Angabe
- ?E-Rechnung verpflichtendkeine Angabe
- ?Vertraulichkeitserklärung verlangtkeine Angabe
- Elektronische Auktionnein
- Aus EU-Mitteln finanziertja
- ?Wiederkehrender Auftragkeine Angabe
Einordnungvon uns ausgewertet
Alle interessierten Unternehmen dürfen ein Angebot abgeben.
Es wird nicht verhandelt. Gewertet wird das Angebot so, wie es eingereicht wurde.
Kein Angebot mehr möglich. Wer gewonnen hat und wie viele Angebote eingingen, steht unter Zuschläge; für Folgeaufträge lohnt der Blick auf Laufzeit und Vergabestelle.
Das Verfahren ist abgeschlossen; diese Meldung nennt das Ergebnis.
Bei dieser Vergabestelle vergehen von der ersten Meldung bis zum Ergebnis im Mittel 122 Tage (268 Verfahren, 24 Monate).
Sie erhält im Median 3 Angebote je Los (994 Lose mit Angabe).
Die Gewichtung von Preis und Leistung steht nicht in der Bekanntmachung, nur in den Vergabeunterlagen.
Unterlagen schon heruntergeladen? Vergabeunterlagen prüfen (Team): Fristen, Gewichtung, Mengen, Zertifikate und Fehler im Preisblatt.
Fristen und TermineStand 07.11.2026
- Veröffentlichungvor 14 Monaten
- Heute
Beschreibung
Access to affordable and high-quality vaccines and medicines is fundamental to ensuring the well-being of any population. Today, Ghana imports 70 % of the pharmaceutical products and 100 % of the vaccines it needs. As in many African nations, this reliance on imported pharmaceutical products is straining both the economy and public health security. The COVID-19 pandemic underscored the vulnerabilities inherent in this dependency, highlighting the importance for self-reliance and resilient healthcare systems.
Ghana is therefore embarking on an ambitious initiative aimed at enhancing local manufacturing capacities for vaccines and medicines to foster availability and accessibility. The pharmaceutical sector has also been identified as an anchor industry for Ghana's industrial transformation and the creation of decent jobs. On the one hand, Ghana"s pharmaceutical industry faces challenges such as cost-intensive procurement of primary products from abroad, a lack of product diversification, high financing costs and a lack of the necessary technologies, technical capacities and skilled workforce. On the other hand, market opportunities are growing and the industry has a strong basis to build on, such as a network of existing local manufacturers, international collaborations for technology transfer, supply, skills development and research, as well as an enabling policy framework. Ghana thus has the potential to become one of the regional vaccine and pharmaceutical manufacturing hubs in Africa.
Building on this momentum, the European Union (EU) and the German Federal Ministry for Economic Cooperation and Development (BMZ) are co-financing the programme "Strengthening the Ghanaian Pharmaceutical Sector with a Focus on Vaccine Production" (PharmaVax Ghana) as part of the Team Europe Initiative (TEI) Manufacturing and Access to Vaccines, Medicines and Health Technologies (MAV+). GIZ is the implementing agency for this EUR33 million technical cooperation programme running from July 2024 to March 2028. The programme"s specific objective is to ensure that the public and private ecosystems of Ghana"s pharmaceutical industry contribute to more competitive local manufacturing of pharmaceutical products. Within this ecosystem approach, the programme works on strengthening key enablers for efficient and sustainable vaccine and pharmaceutical manufacturing in Ghana. In particular, it focuses on four key result areas (components): (1) Governance & Regulation: Enhancing the capacities of Ghanaian public actors to effectively govern, coordinate and regulate pharmaceutical and vaccine manufacturing (2) Skills Development: Institutionalising practice-oriented, gender-responsive skills development measures needed to grow pharmaceutical and vaccine production capacities in Ghana (3) Research & Development (R&D): Fostering Ghanaian research institutions" applied R&D capacities and industry partnerships to stimulate local innovation in pharmaceutical and vaccine development and manufacturing (4) Private Sector Development: Enabling Ghanaian pharmaceutical and vaccine manufacturers to comply with good practices, become attractive for international partnerships and grow their business
Ghana"s Ministry of Finance (MoF) is the programme"s political partner, with the Ministry of Trade and Industry (MoTI) and the National Vaccine Institute (NVI) being the key Ghanaian implementing partners. The programme also works in collaboration with the Food and Drugs Authority (FDA), line ministries for health, education and sciences, Ghana"s pharmaceutical manufacturers, private sector associations as well as relevant research and training institutions and it will create linkages with other African, European and international initiatives, research institutions and companies.
GIZ intends to contract a service provider for the implementation of two work packages within component 2 of the PharmaVax Ghana the programme.
Beschreibung des Loses
This assignment contributes to the overall objective of the PharmaVax Ghana programme to ensure that the public and private ecosystems of Ghana"s pharmaceutical industry contribute to more competitive local manufacturing of pharmaceutical products. Specifically, the assignment supports the achievement of the specific objectives and indicators related to component 2 on skills development. Component aims to improve access to practice-oriented and gender-responsive training courses on specialized skill sets needed to grow pharmaceutical and vaccine production sector in Ghana. The hypothesis is that pharmaceutical manufacturers can find and hire qualified workers and professionals locally and engage them in a productive and lucrative local pharmaceutical value chain from R&D and production. This is based on the assumption that private sector stakeholders (including manufacturers) will work together in developing and establishing long-term hands-on training opportunities for needed skills sets. Key partners are Ghanaian vocational and higher education training institutions as well as the public and private sector stakeholders of the pharmaceutical manufacturing sector, in particular manufacturers themselves.
The contractor is responsible for the following two work packages and for achieving the corresponding milestones. These work packages fall under component 2 but there are potentials for synergies and thus need for coordination to the other components, as well as to further activities under component 2 implemented by the GIZ team or financing recipients.
Work package A: Vocational training for the pharmaceutical sector
In addition to highly trained and specialist workers, production floor staff such as qualified machine operators as well as maintenance technicians are needed to expand production and ensure effective and efficient operations. The contractor will support the introduction of a formal technical and vocational education and training (TVET) programme in the area of "pharmaceutical manufacturing process technology" (curricula have already been developed). The training is to be implemented to begin with at one training institution in Accra. If demand and resources allow, it might be expanded in the second year to a second training institution, preferably in Kumasi as the second pharmaceutical industrial centre of the country. Key areas include: 1. Preparation of a detailed implementation concept and plan: 2. training institution(s), qualification levels, target groups, entry requirements, cohort sizes, course duration and training modalities 3. Development of a costing model and a financial and institutional sustainability plan, including fees/pricing/stipends, resource mobilization and partnerships etc. 4. Mobilisation of local and international private sector partners for supporting training implementation 5. Identification of school-based and in-company trainers; finalisation of training materials; delivery of technical and didactical trainings of trainers according to national and, where possible, international standards 6. Mobilisation and procurement of equipment, tools and equipment as well infrastructural upgrades of training institution(s) 7. National accreditation of training institutions, international accreditations and certifications where possible 8. Gender-transformative career guidance and course promotion and gender equitable selection of qualified participants 9. Training delivery at training institution(s) and in companies (workplace experience learning); support to trainees, training institutions, participating companies, trainers; Examination of trainees, recognition of prior learning where appropriate; support to the labour market integration of trainees 10. Monitoring, evaluation and learning, including review and adaptation of course contents, materials and delivery approaches for future cohorts; tracing of graduates
Work package B: Higher education and specialist trainings
The contractor will provide technical advice and assistance to develop at least ten required capacity development measures for qualified specialists in the pharmaceutical sector, on a sustainable basis and in collaboration with well-established institutions for higher-education and specialist trainings in Ghana (e.g. Noguchi Memorial Institute for Medical Research, Kumasi Centre for Collaborative Research). Each course shall be run twice with support from the contractor. The subjects of the short courses are to be determined depending on the needs of the pharmaceutical industry in Ghana but could include areas such as vaccine immunology; bacterial genomics and bioinformatics; good laboratory practice; clinical trials management and monitoring; maintenance training on some advanced equipment used in clinical trials; vaccinology; GMP principles in vaccine manufacturing; biopharmaceuticals and biosimilars development, production, analytics; cGMP compliance and consumer safety; cGMP inspection; pharmaceutical validation management; ICH Q9 quality risk Management; ICH 8 and 9; cleaning validation; data integrity and documentation; dossier development; analytical method validation; product quality review; change management and product lifecycle; drug safety and pharmacovigilance; equipment and facility qualification; engineering.
For each course, this includes notably the follow main tasks: 1. Development of course materials together with training institutions and private sector 2. Identification of trainers 3. Set up of infrastructure / Procurement of reagents and equipment 4. Promotion of the course 5. Selection of participants 6. Certification 7. Sustainability concept
Bidders are required to provide 2 key experts (1 team leader and 1 technical expert) as well as expert pools (national and internation expertise). The tender also includes provision of equipment for partners, activities, travel costs for the experts and loclal subcontracts.
Bedingungen
Zuschlag3 von 3 angegeben
- Preis
- PriceGewichtung (Punkte, genau) 30Consideration of the price through the valuation method "Bestangebots-Quotienten-Methode"
- Qualität
- Total points achieved after technical evaluation (including minimum requirements)Gewichtung (Punkte, genau) 70In order to determine the most economical bidder, the contracting authority enters the total number of points achieved after technical evaluation. Only bids with a technical evaluation of at least 500 points are considered. Technical bids with fewer points are rejected as technically unsuitable.
- Qualität
- Total points achieved after technical evaluation (including minimum requirement)In order to determine the most economical bidder, the contracting authority enters the total number of points achieved after technical evaluation. Only bids with a technical evaluation of at least 500 points are considered. Technical bids with fewer points are rejected as technically unsuitable.
Eignung0 von 2 angegeben
- Kriterien
- ?keine Angabe
- Nachreichen von Unterlagen
- ?keine Angabe
Laufzeit und Umfang4 von 6 angegeben
- Vertragsbeginn
- ?keine Angabe
- Vertragsende
- ?keine Angabe
- Dauer
- 24 Monate
- Verlängerung
- bis zu 2-mal: GIZ may optionally commission contract amendments and/or increases based on the criteria in the tender documents to the successful bidder of this tender. For details, please see the terms of reference.
- Optionen
- GIZ may optionally commission contract amendments and/or increases based on the criteria in the tender documents to the successful bidder of this tender. For details, please see the terms of reference.
- Rahmenvereinbarung
- nein
Angebot und Einreichung0 von 8 angegeben
- Elektronische Einreichung
- ?keine Angabe
- Einreichung über
- ?keine Angabe
- Sprache
- ?keine Angabe
- Nebenangebote
- ?keine Angabe
- Mehrere Hauptangebote
- ?keine Angabe
- Bindefrist
- ?keine Angabe
- Angebotsöffnung
- ?keine Angabe
- Sicherheiten
- ?keine Angabe
Ausführung2 von 5 angegeben
- Vertraulichkeit
- ?keine Angabe
- E-Rechnung
- ?keine Angabe
- Vorbehaltene Ausführung
- ?keine Angabe
- Strategische Beschaffung
- Verringerung der Auswirkungen auf die Umwelt, Erfüllung sozialer Zielsetzungen
- EU-Mittel
- Auftragsvergabeprojekt ganz oder teilweise aus EU-Mitteln finanziert
Rechtsschutz3 von 3 angegeben
- Nachprüfungsstelle
- Vergabekammern des Bundes, Kaiser-Friedrich-Straße 16, 53113 Bonn
- Fristen für Nachprüfungsanträge
According to Article 160, Section 3 of the German Act Against Restraint of Competition (GWB), application for review is not permissible insofar as 1. the applicant has identified the claimed infringement of the procurement rules before submitting the application for review and has not submitted a co … ganz lesenkürzer
According to Article 160, Section 3 of the German Act Against Restraint of Competition (GWB), application for review is not permissible insofar as 1. the applicant has identified the claimed infringement of the procurement rules before submitting the application for review and has not submitted a complaint to the contracting authority within a period of 10 calendar days; the expiry of the period pursuant to Article 134, Section 2 remains unaffected, 2. complaints of infringements of procurement rules that are evident in the tender notice are not submitted to the contracting authority at the latest by the expiry of the deadline for the application or by the deadline for the submission of bids, specified in the tender notice. 3. complaints of infringements of procurement rules that first become evident in the tender documents are not submitted to the contracting authority at the latest by the expiry of the deadline for application or by the deadline for the submission of bids, 4. more than 15 calendar days have expired since receipt of notification from the contracting authority that it is unwilling to redress the complaint. Sentence 1 does not apply in the case of an application to determine the invalidity of the contract in accordance with Article 135, Section 1 (2). Article 134, Section 1, Sentence 2 remains unaffected.- Beschaffungsübereinkommen (GPA)
- fällt darunter
Zusätzliche Informationen2 von 2 angegeben
- Hinweis
- The contracting authority reserves the right to purchase services consisting of the repetition of similar services entrusted to the undertaking to which the same contracting authority awarded an initial contract, provided that these services are in conformity with a basic project for which the initial contract was awarded. (see Sec. 14 para. 4 no. 9 Public Procurement Regulation).
- Hinweis
- Bekanntmachungs-ID: CXTRYY6YTAAPJ0AM All communication takes place in English via communication tool in the project area of the procurement portal.
Keine Angabe passt zu diesem Suchbegriff.
Bezeichnungen aus den amtlichen eForms-Codelisten (EU und eForms-DE). Maßgeblich sind die Vergabeunterlagen.
Zuschläge
| Zuschlag an | Angebote |
|---|---|
| GFA Consulting Group GmbH, Hamburg | 2 |
AuftraggeberZur Seite der Vergabestelle
- Anschrift
- Dag-Hammarskjöld-Weg 1 - 5, 65760 Eschborn
- Website
- giz.de
- Kontakt
- giz.ausschreibungen@
fgvw.de
Bei uns erfasst
- Electrical Equipment and Cables06.11.2026
- 10047547-CONFIDENTIAL PROGRAMME OF MEASURES (PoMs) FOR BARAK RIVER BASIN MANAGEMENT PLAN USING RBM CYCLE APPROACH05.11.2026
- 100586746-UNDP-Fachkonferenz - 02.-04.12.2026 in Bonn05.11.2026
- 10044905 - Kommunikationsberatung für das Globalvorhaben Verantwortungsvolle Land Governance05.11.2026
Mehr von Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH
- 10060870-Étude d"opportunité et de faisabilité de la plateforme SNIFDeutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH · RabatFrist 26.11.2026
- PV-plant for ChadDeutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH · EschbornFrist 12.11.2026
- 10062071 - WärmepumpenDeutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH · EschbornFrist 19.11.2026
- 10017688 - National Information Sharing and Analysis FrameworkDeutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH · EschbornFrist 04.12.2026
Alle 68 offenen Ausschreibungen von Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH, dazu Zuschläge und Auftragnehmer
Marktumfeldvon uns ausgewertet
Vergabemeldungen der letzten 24 Monate mit Hauptgegenstand CPV 850 (Dienstleistungen des Gesundheits- und Sozialwesens) in Hessen. Abgeleitet aus veröffentlichten Bekanntmachungen, keine amtliche Statistik. Zuschlagswerte unter 1.000 € zählen wir als Platzhalter nicht mit.
Mehr Marktdaten, Vergabestellen und offene Ausschreibungen: Dienstleistungen in Hessen (154 offen)
Preise und WettbewerbPremium
Verlauf des Verfahrens4 Meldungen
- Vergabebekanntmachung (diese Seite)
- BekanntmachungFrist 06.06.2025
- 1. Berichtigung · Informationen sind jetzt verfügbarFrist von 06.06.2025 auf 13.06.2025 verschoben
- 1. Berichtigung · Aktualisierte InformationenFrist 13.06.2025
Berichtigte Fassungen bleiben aufrufbar. Die Suche zeigt je Verfahren nur die aktuelle.
Ähnliche offene Ausschreibungen
- 10032371 - Strengthening reproductive health and empowerment of young womenDeutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbHFrist 23.11.2026
- Glasreinigung für 2027DRV Bund Reha-Zentrum Bad StebenFrist 09.11.2026
- Pooling von Schulassistenz an der Förderschule Ottenbeck im Landkreis StadeLandkreis StadeFrist 25.11.2026
- Arbeitsmedizinische Betreuung - 2 Jahre zzgl. VerlängerungErftverbandFrist 24.11.2026
- Rahmenvertrag Konflikt- und Sozialberatung fuer die SenWiEnBeSenatsverwaltung fuer Wirtschaft, Energie und BetriebeFrist 10.11.2026
- Präventive GesundheitsmaßnahmeStadt Frankfurt am Main, BranddirektionFrist 17.11.2026
Quelle: Bekanntmachungsservice des Bundes (oeffentlichevergabe.de), Lizenz CC0. Stand der Daten: 03.11.2026. Maßgeblich ist allein die Originalbekanntmachung. Kennung 7ba9d831-e373-43d3-b53b-f027ef54b94d.